Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.90% | -5.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.28% | -29.57% | |||
| Operating Income | 10.28% | 29.57% | |||
| Income Before Tax | 9.45% | 29.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.45% | 29.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.45% | 29.33% | |||
| EBIT | 10.28% | 29.57% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 13.20% | 29.79% | |||
| Normalized Basic EPS | 13.14% | 29.83% | |||
| EPS Diluted | -73.67% | 29.79% | |||
| Normalized Diluted EPS | 13.14% | 29.83% | |||
| Average Basic Shares Outstanding | 4.32% | 0.67% | |||
| Average Diluted Shares Outstanding | 4.32% | 0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||